MedPath

Clinical study on the prevention and treatment of colorectal adenoma by regulating intestinal microecology: a randomized double-blind controlled trial

Phase 1
Recruiting
Conditions
colorectal adenoma
Registration Number
ITMCTR2000003350
Lead Sponsor
Shuguang Hospital affillated with Shanghai University of TCM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Adenoma was definitely diagnosed by pathology, and the patients were between 18 and 75 years old.
2. The TCM syndrome type was consistent with cold and wet stasis syndrome or dampness and heat accumulation syndrome.
3. Patients with no previous history of colorectal surgery, cholecystectomy, familial adenomatous polyposis or hereditary non-polyposis colorectal cancer, or inflammatory bowel disease;
4. Not taking antibiotics, immunosuppressive agents, hormones or other drugs within three months;
5. Those who ate a relatively stable diet and voluntarily signed the informed consent.

Exclusion Criteria

1. The patients have digestive tract diseases, metabolic diseases, cardiovascular diseases, immune diseases, liver diseases, neurological diseases and autoimmune diseases.
2. Regular long-term use of yogurt or probiotics (2-3 times/week for more than 6 months);
3. Pregnant and lactating women;
4. To be allergic to a drug in a Chinese medicine prescription;
5. Has participated in other clinical investigators;
6. The researcher considers it inappropriate to participate in this experiment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
recurrence rate;
Secondary Outcome Measures
NameTimeMethod
Bacterial metabolites;Characteristics and pathological types of adenoma;Intestinal microbiota structure;
© Copyright 2025. All Rights Reserved by MedPath